These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17041343)

  • 1. Ciprofloxacin-related acute peripheral neuropathy in a patient with lupus nephritis.
    Singh J
    J Clin Rheumatol; 2002 Jun; 8(3):143-6. PubMed ID: 17041343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin-Induced Peripheral Neuropathy: A Case Report.
    Refaeian A; Vest EL; Schmidt M; Guerra JD; Refaei MN; Refaeian M; Floresca RA; Refaeian M
    HCA Healthc J Med; 2023; 4(5):383-387. PubMed ID: 37969850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Acute Axonal Neuropathy Induced by Ciprofloxacin: A Case Report.
    Popescu C
    Case Rep Neurol; 2018; 10(2):124-129. PubMed ID: 29928218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy--a rare complication of paediatric systemic lupus erythematosus.
    Sridhar AV; Gosalakkal J; Pye IF; Houtman P
    Eur J Paediatr Neurol; 2004; 8(5):253-6. PubMed ID: 15341908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Motor Axonal Neuropathy in Lupus Nephritis.
    Bodra D; D'Souza AVL; Khan E
    Cureus; 2024 Mar; 16(3):e55603. PubMed ID: 38586696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent Peripheral Neuropathy: A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration.
    Francis JK; Higgins E
    J Investig Med High Impact Case Rep; 2014; 2(3):2324709614545225. PubMed ID: 26425618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological approach to peripheral neuropathy. Conventional nerve conduction studies and magnetic motor root stimulation].
    Ugawa Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):986-90. PubMed ID: 15651350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy in pediatric systemic lupus erythematosus.
    Harel L; Mukamel M; Brik R; Blau H; Straussberg R
    Pediatr Neurol; 2002 Jul; 27(1):53-6. PubMed ID: 12160975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of peripheral neuropathy with insulin-dependent diabetes mellitus.
    Bao XH; Wong V; Wang Q; Low LC
    Pediatr Neurol; 1999 Mar; 20(3):204-9. PubMed ID: 10207929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Limb myokymia with involuntary finger movement caused by peripheral neuropathy due to systemic lupus erythematosus (SLE)--a case report].
    Hara H; Wakayama Y; Yamada H; Kouno Y; Kawasaki H
    Rinsho Shinkeigaku; 1994 Jul; 34(7):717-9. PubMed ID: 7955731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
    Singh S; Stroud AM; Holubar SD; Sandborn WJ; Pardi DS
    Cochrane Database Syst Rev; 2015 Nov; (11):CD001176. PubMed ID: 26593456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extremely acute phenytoin-induced peripheral neuropathy.
    Yoshikawa H; Abe T; Oda Y
    Epilepsia; 1999 Apr; 40(4):528-9. PubMed ID: 10219285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis.
    Lien YH; Hansen R; Kern WF; Bangert J; Nagle RB; Ko M; Siskind MS
    Am J Kidney Dis; 1993 Oct; 22(4):598-602. PubMed ID: 8213803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report.
    Habuka M; Wada Y; Kurosawa Y; Yamamoto S; Tani Y; Ohashi R; Ajioka Y; Nakano M; Narita I
    BMC Res Notes; 2018 Mar; 11(1):165. PubMed ID: 29506558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.
    Camdessanché JP; Antoine JC; Honnorat J; Vial C; Petiot P; Convers P; Michel D
    Brain; 2002 Jan; 125(Pt 1):166-75. PubMed ID: 11834602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.